Drugs / Allogeneic Hepatocyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04806581 | Apr 2021 → Dec 2024 | cirrhosis of liver | RenJi Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Hepatocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04806581 ↗ |
| Modality | Cell therapy | “allogeneic hepatocyte transplantation” NCT04806581 ↗ |